Physician profile
Prospero E Matos
NPI 1629359781
$660.22
in general payments reported to CMS, 2019-2025
13 companies · $95.10 in 2025
The $95.10 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.23 · 2020: $65.76 · 2021: $195 · 2022: $119 · 2023: $32.76 · 2024: $77.55 · 2025: $95.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $189 · Honoraria: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $189.30 |
| Honoraria | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $156.48 | 2020-2024 | Invisalign |
| Carestream Dental, LLC | $100.25 | 2019-2022 | |
| Salvin Dental Specialties, INC. | $92.24 | 2021 | |
| Straumann USA LLC | $58.11 | 2025 | |
| 3m Company | $51.84 | 2022-2023 | Scotchbond Universal |
| A-Dec, INC. | $45.00 | 2019 | |
| Solventum Corporation | $41.59 | 2024-2025 | 3m Scotchbond, Clinpro 5000 |
| Dentsply Sirona INC | $29.48 | 2019-2025 | Q-Mix |
| Kulzer, LLC | $21.77 | 2021 | |
| Philips North America LLC | $18.04 | 2020 | |
| Nobel Biocare USA | $17.24 | 2022 | |
| Benco Dental Supply Co. | $16.11 | 2023 | |
| Kerr Corporation | $12.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prospero Matos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.